|
SERD* + everolimus Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Pipeline
Phase 2: 1
Top Sponsors
- UNC Lineberger Comprehensive Cancer Center1
Indications
- Estrogen Receptor-positive Breast Cancer1
- Hormone Receptor-Negative Breast Carcinoma1
- Metastatic Breast Cancer1
- Triple Negative Breast Cancer1
- Breast Cancer1
Rochester, Minnesota1 trial
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.